newsfilter
← Latest News
GlobeNewswire·

Pardes Biosciences to Present at Jefferies London Healthcare Conference

CARLSBAD, Calif., Nov. 01, 2022 (GLOBE NEWSWIRE) -- Pardes Biosciences, Inc. (NASDAQ:PRDS), a clinical-stage biopharmaceutical company developing PBI-0451 as a potential stand-alone novel direct-acting, oral antiviral